The Human Genome Project identified approximately 25,000 genes in the human genome and created the possibility for personalized medicine.
The NKI hypothesized that breast cancer is a genetic, heterogeneous disease, where gene expression would be different in aggressive breast tumors that develop recurrences following surgery than from those that are less aggressive and do not recur or spread throughout the body.